Study of Antihypertensive and Antiplatelet Use in Outpatient Preeclampsia Patients at Siti Khodijah Sepanjang Hospital

https://doi.org/10.22146/jmpf.98249

Uchti Firda Purwanti(1), Selly Septi Fandinata(2*)

(1) Akademi Farmasi Surabaya, Surabaya, East Java
(2) Fakultas Farmasi, Universitas STRADA Indonesia
(*) Corresponding Author

Abstract


Background: Preeclampsia is a complication of pregnancy characterized by increased blood pressure and the presence of proteinuria after reaching 20 weeks of gestation. Besides that, the diagnosis of preeclampsia can be reinforced by other symptoms such as edema, impaired liver and kidney function.

Objectives: This study aims to investigate the usage of antihypertensive and antiplatelet medications in outpatient preeclampsia patients at Siti Khodijah Sepanjang Hospital from January 2022 to December 2023.

Methods: Data collection method is retrospective, obtained from medical records of 70 preeclampsia patients. The sampling technique using purposive sampling method according to the inclusion research criteria. Data was analyzed using Microsoft Excel 2021.

Results: Data on drug usage profiles obtained during the treatment, shows that the most common combination is a combination of two antihypertensive drugs and an antiplatelet, namely metildopa (category B) + aspirin (category C), with a dosage of 500 mg + 80 mg per day. The medication regimen is S2dd1 + S1dd1, and the average duration of treatment ranges from 7 to 30 days. With this treatment, the blood pressure of preeclampsia patients experienced a change in the patient's blood pressure which decreased in 65 patients with the initial classification of mild preeclampsia being 54 patients to normal in the final preeclampsia classification of 56 patients

Conclusion: This study provides several important implications for health workers in Indonesia in the management of preeclampsia disease with the use of antihypertensive and antiplatelet drugs, so that they can provide services that are in accordance with the medical needs of patients.


Keywords


Pregnancy; Preeclampsia; Antihypertensive; Antiplatelet

Full Text:

PDF


References

  1. Nainggolan M. Gambaran Pengetahuan, Sikap Dan Tindakan Ibu Hamil Terhadap Risiko Hipertensi Di Puskesmas Glugur Darat Kecamatan Medan Timur. Poltekkes Kemenkes Medan. Published online 2019.
  2. Andriana DD, Utami ED, Sholihat NK. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Pre-Eklampsia Rawat Inap di RSUD Prof. Dr. Margono Soekarjo Purwokerto. Acta Pharm Indones Acta Pharm Indo. 2018;6(1):29. doi:10.20884/1.api.2018.6.1.1445
  3. Rahajeng E, Tuminah S. Hidup Bersama Hipertensi. Maj Kedokt Indon. 2009;59(12):580-587. doi:10.22146/jmpf.40929
  4. WHO, UNICEF, UNFPA, Division WBG and the UNP. Trends In Maternal Mortality 2000 to 2017. N Z Med J. 2019;65(402):80-86.
  5. Kemenkes RI. Profil Kesehatan Indonesia 2021. Kemenkes RI. Published online 2022.
  6. Dinkes Provinsi Jatim. Profil Kesehatan Jawa Timur Tahun 2021.; 2022. doi:10.21831/dinamika.v3i1.19144
  7. Dinkes Kab. Sidoarjo. Profil Kesehatan Kabupaten Sidoarjo Tahun 2022. Dinas Kesehat Kabupaten Sidoarjo. Published online 2022:200.
  8. Aulia Ramdini D, Koernia Wahidah L, Atika D. Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe Ii Pada Pasien Rawat Jalan Di Puskesmas Pasir Sakti Tahun 2019. JFL J Farm Lampung. 2021;9(1):69-76. doi:10.37090/jfl.v9i1.334
  9. POGI. PNPK Diagnosis dan Tatalaksana Preeklampsia. Published online 2016:1-48.
  10. Ramadhan MFY, Mulyani T, AriyanI H. EVALUASI PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN PREEKLAMPSIA RAWAT INAP DI RSUD DATU SANGGUL RANTAU. 2022;5(2):514-523.
  11. Yana AU, Brata C, Irawati S. Studi Penggunaan Antihipertensi pada Pasien Preeklampsia Rawat Jalan di Poliklinik Rumah Sakit Ibu dan Anak Surabaya Use of Antihypertensives Drugs in Patients with Preeclampsia at the Mother and Child Hospital Outpatient Polyclinic in Surabaya. 2023;14(2):319-326.
  12. Artikasari K. Hubungan Antara Primigravida Dengan Angka Kejadian Preeklamsia/Eklamsia Di Rsud Dr. Moewardi Surakarta Periode 1 Januari – 31 Desember 2008. Univ Muhammadiyah Surakarta. 2009;45(1):1-19.
  13. Fandinata SS, Darmawan R, Utami PR, Ulfa NM. Monitoring Kidney Function Through the Use of Candesartan, Telmisartan or Valsartan Antihypertensive Therapy towards Patients CKD. Media Kesehat Masy Indones. 2022;18(1):1-9. doi:10.30597/mkmi.v18i1.17780
  14. Selly Septi Fandinata, Rizky Darmawan, Ninik Mas Ulfa DAP. Changes in Mean Arterial and Blood Pressure in Using Nicardipine in Hypertensive Crisis Patients at the Hajj General Hospital Surabaya from August to December 2021. Borneo J Pharm. 2023;6(1):79-86. doi:10.33084/bjop.v6i1.3493
  15. Pratiwi I. Hubungan Paritas Dengan Kejadian Preeklampsia Pada Ibu Hamil Di Rsud Wonosari. Stikes Aisyiyah Yogyakarta. 2015;151(september 2016):10-17. doi:10.1145/3132847.3132886
  16. Food Drug and Administration. Advisory Commite for Pharmaceutical Science. FDA USA; 2004.
  17. Dipiro, J. T.; Talbert, R. L.; Yee, G. C.; Matzke, G. R.; Wells BG. P, LM. Pharmacotherapy A Pathophysiologic Approach. Mc Graq Hill Companie; 2011.
  18. Iskandar F, Limardi, Suryadi, Padang, Fransisca A. Aspirin Dosis Rendah untuk Pencegahan Preeklampsia dan Komplikasinya. Cermin Dunia Kedokt. 2017;44(5):362-365.
  19. Arminda F, Rodiani. Aspirin Dosis Rendah Sebagai Usaha Preventif Untuk Ibu yang Berisiko Tinggi Terkena Preeklampsia. J Ilm Mhs Kedokt Indones. 2020;8(1):44-51.
  20. Guidelines QC. Maternity and Neonatal Clinical Guideline. Queensl Heal. Published online 2021:1-39.
  21. Cunningham F. G, et al. Obstetri William Edisi 23.; 2014.
  22. Riza Restiana, Ernawati A. Pengaruh Paritas Dan Hemoglobin Terhadap Kejadian Preeklamsia 340. 2016;4(1):1-23.
  23. Kibas AAR, Latuconsina VZ, Maelissa MM. Hubungan Jumlah Leukosit Dengan Kejadian Preeklamsia Di Rsud Dr. M. Haulussy Ambon Tahun 2018. PAMERI Pattimura Med Rev. 2021;3(2):70-76. doi:10.30598/pamerivol3issue2page78-83



DOI: https://doi.org/10.22146/jmpf.98249

Article Metrics

Abstract views : 334 | views : 124

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats